Impact of X-Waiver Elimination on Post–Hospital Discharge Buprenorphine Prescribing: An Interrupted Time Series Analysis
The elimination of the X-waiver does not appear to have altered buprenorphine prescribing practices in the short term, which suggests that long-term studies and additional strategies may be needed to address persistent barriers to effective treatment for OUD.
Authors
- Brian S. Barnett (ORCID: https://orcid.org/0000-0002-8963-5701)
- Gabriel P. A. Costa (ORCID: https://orcid.org/0009-0007-8702-5436)
- Philip R. Wang (ORCID: https://orcid.org/0000-0003-2973-529X)
- Lukas Bobak (ORCID: https://orcid.org/0000-0003-4000-6880)
- Ian Dorney (ORCID: https://orcid.org/0000-0002-2520-0557)
- Edward J. Mascha (ORCID: https://orcid.org/0000-0002-0451-1196)
- Akhil Anand (ORCID: https://orcid.org/0000-0003-4132-2690)
- Yufei Li (ORCID: https://orcid.org/0000-0001-5940-4606)
Institutions
- Brigham and Women's Hospital (US)
- Cleveland Clinic (US)
- Mount Sinai Hospital (US)
- School of the Art Institute of Chicago (US)
- University of Michigan (US)
- Yale University (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Michigan Medicine (US)
- The Neurological Institute (US)
- Case Western Reserve University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1097/adm.0000000000001568
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00